Literature DB >> 16338158

Screening for undiagnosed parkinsonism in people aged 65 years and over in the community.

K S M Taylor1, C E Counsell, C E Harris, J C Gordon.   

Abstract

We screened a random sample of 2449 people aged 65 years and over for undiagnosed parkinsonism, using a postal screening questionnaire followed by clinical neurological assessment. Amongst the 1556 (63.5%) patients who responded, four patients with previously undiagnosed parkinsonism were identified, suggesting a prevalence of 257 per 100,000 (95% CI 70, 658) in this age-group. Although only small, the numbers were sufficient to significantly increase the incidence of parkinsonism in an incidence study. Two simple screening questions achieved a high sensitivity for newly diagnosed parkinsonism of 95%, but a low specificity of 28%.

Entities:  

Mesh:

Year:  2005        PMID: 16338158     DOI: 10.1016/j.parkreldis.2005.08.005

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  5 in total

Review 1.  Screening questionnaires for parkinsonism: a systematic review.

Authors:  Nabila Dahodwala; Andrew Siderowf; Mona Baumgarten; Aaron Abrams; Jason Karlawish
Journal:  Parkinsonism Relat Disord       Date:  2011-09-17       Impact factor: 4.891

2.  Parkinson's disease misdiagnosed as stroke.

Authors:  Robert Caslake; Kate S M Taylor; Carl E Counsell
Journal:  BMJ Case Rep       Date:  2009-02-02

3.  The impact of DaTscan on the diagnosis and management of movement disorders: A retrospective study.

Authors:  Kimberly D Seifert; Jonathan I Wiener
Journal:  Am J Neurodegener Dis       Date:  2013-03-08

4.  Can a screening questionnaire accurately identify mild Parkinsonian signs?

Authors:  Nabila Dahodwala; Lee Kubersky; Andrew Siderowf
Journal:  Neuroepidemiology       Date:  2012-08-29       Impact factor: 3.282

5.  Parkinson's disease case ascertainment in prospective cohort studies through combining multiple health information resources.

Authors:  Marije Reedijk; Anke Huss; Robert A Verheij; Petra H Peeters; Roel C H Vermeulen
Journal:  PLoS One       Date:  2020-07-01       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.